Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Research Article Volume 4 Issue 2

Breast Cancer in Central Iran: Estimated Incidence and Trend in Isfahan Province During 30 Years

Reza Sirous1, Raheleh Taghvaei2, Salimeh Sirous3, Mehri Sirous4, Fatemeh Dehghani Firouzabadi5, Shamila Razavi4, Farnaz Khalighi Nejad4, Vida Razavi4, Forough Yazdanian6, Saeedeh Rafiee7, Athena Farahzadi7 and Ziba Farajzadegan*8

1Department of Radiology and Nuclear Medicine, University of Maryland Medical Center-Address: 22 S Greene St, Baltimore, USA
2Department of Radiology, University of Pennsylvania- Philadelphia, USA
3Department of Surgery, Universitätsklinikum Knappschaftskrankenhaus Bochum- In der Schornau, Bochum, Germany
4Department of Radiology, Isfahan University of Medical Sciences- Hezar Jerib Ave, Isfahan, Iran
5Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran
7Minimally Invasive Surgery Research Center, Rasoul-e- Akram hospital, Iran University of Medical Sciences, Tehran, Iran
8Department of Preventive Medicine, Isfahan University of Medical Sciences- Hezar Jerib Ave, Isfahan, Iran

*Corresponding Author: Ziba Farajzadegan, Department of Preventive Medicine, Isfahan University of Medical Sciences- Hezar Jerib Ave, Isfahan, Iran. E-mail:farajzadegan@med.mui.ac.ir Department, Iran.

Received: December 23, 2020; Published: January 30, 2021

×

Abstract

Background: Breast cancer is not only one of the most common cancers in Iran, but is also a leading cause of cancer-related mortality in Iranian women. Evidence suggests that breast cancer occurs in Iranian women 10 years earlier than their peers in developed countries. To provide reliable estimates of the incidence and trend of breast cancer in central Iran, we conducted a cross-sectional study in Isfahan Province.

Methods: We calculated the incidence and trend of breast cancer during 1980-2010 in Isfahan Province, as the most populous metropolitan city in central Iran. We conducted this cross-sectional study in four major screening mammography centers during 2012-2014 to collect data regarding the patients’ breast disease history. The final study sample consisted of 7883 women, 1275 of whom were diagnosed with breast cancer. Next, a retrospective cohort analysis was conducted on patients with breast cancer. Crude and age-standardized incidence rates (ASIR) were also calculated.

Results: During 2005-2010, ASIR was measured to be 40.4 per 100,000 person-years. The mean age of patients at the time of breast cancer diagnosis was 43.5 years (SD=8.2). The findings showed that the incidence rate of breast cancer increased steadily from 8.3 to 40.4 per 100,000 person-years from 1980 to 2010.

Conclusion: A significant increase was observed in the incidence of breast cancer, and a younger age of onset was reported in a major province over the past three decades.

Keywords: Breast Cancer; ASIR; Years of Life Lost (YLL)

×

References

  1. Global Burden of Disease Cancer C., et al. “The Global Burden of Cancer 2013”. JAMA Oncology4 (2015): 505-527.
  2. Forouzanfar MH., et al. “Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis”. Lancet 9801 (2011): 1461-1484.
  3. Ferlay J., et al. “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012”. International Journal of Cancer 5 (2015): E359-386.
  4. Moore MA., et al. “Cancer epidemiology and control in North-Western and Central Asia - past, present and future”. Asian Pacific Journal of Cancer Prevention : APJCP 11 (2010): 17-32.
  5. Naderimagham S., et al. “National and sub-national burden of breast cancer in Iran 1990-2013”. Archives of Iranian Medicine 12 (2014): 794-799.
  6. Tajvidi M., et al. “Partial frequency of radiation pneumonitis and its association with the energy and treatment technique in patients with breast cancer, Isfahan, Iran”. Journal of Research in Medical Sciences 5 (2013): 413-416.
  7. Jafari-Koshki T., et al. “Trends of breast cancer incidence in Iran during 2004-2008: a Bayesian space-time model”. Asian Pacific Journal of Cancer Prevention : APJCP 4 (2014): 1557-1561.
  8. Mousavi SM., et al. “Breast cancer in Iran: an epidemiological review”. Breast Journal4 (2007): 383-391.
  9. Naing NN. “Easy way to learn standardization : direct and indirect methods”. The Malaysian Journal of Medical Sciences : MJMS1 (2000): 10-15.
  10. Harirchi I., et al. “Breast cancer in Iran: results of a multi-center study”. Asian Pacific Journal of Cancer Prevention : APJCP 1 (2004): 24-27.
  11. Hosseini MS., et al. “Age - specific incidence rate change at breast Cancer and its different histopathologic subtypes in Iran and Western countries”. Pakistan Journal of Medical Sciences 6 (2013): 1354-1357.
  12. Hemminki K., et al. “Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden”. Oncologist2 (2011): 146-154.
  13. Babu GR., et al. “Breast cancer screening among females in Iran and recommendations for improved practice: a review”. Asian Pacific Journal of Cancer Prevention : APJCP 7 (2011): 1647-1655.
  14. Rezaianzadeh A., et al. “Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran”. BMC Cancer 9 (2009): 168.
  15. Sadjadi A., et al. “Cancer occurrence in Iran in 2002, an international perspective”. Asian Pacific Journal of Cancer Prevention : APJCP 3 (2005): 359-363.
  16. Hashemzadeh S., et al. “The incidence of breast cancer in northwest Iran (2003 -2008)”. Journal of Cardiovascular and Thoracic Research 1 (2012): 5-9.
  17. Sadjadi A., et al. “Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry”. Eastern Mediterranean Health Journal 6 (2009): 1426-1431.
  18. Iran Census Results 2011, Iran Portal Data (2011).
  19. Goovaerts P and Gebreab S. “How does Poisson kriging compare to the popular BYM model for mapping disease risks?” International Journal of Health Geographics 7 (2008): 6.
  20. McCormack VA., et al. “International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries”. Cancer Epidemiology 40 (2016): 141-151.
  21. Mousavi SM., et al. “Cancer incidence and mortality in Iran”. Annals of Oncology3 (2009): 556-563.
  22. Mehrabani D., et al. “Incidence of breast cancer in Fars province, southern Iran: a hospital-based study”. World Journal of Plastic Surgery 1 (2012): 16-21.
  23. Afsharfard A., et al. “Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study”. Asian Pacific Journal of Cancer Prevention : APJCP 11 (2013): 6905-6911.
  24. Harirchi I., et al. “Twenty years of breast cancer in Iran: downstaging without a formal screening program”. Annals of Oncology1 (2011): 93-97.
  25. Burton A., et al. “Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems”. Breast Cancer Research1 (2016): 130.
  26. Montazeri A., et al. “Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods”. Asia Pacific Family Medicine 1 (2008): 6.
  27. Farajzadegan Z., et al. “The transtheoretical model, health belief model, and breast cancer screening among Iranian women with a family history of breast cancer”. Journal of Research in Medical Sciences1 (2016): 122.
  28. Montazeri A., et al. “Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study”. BMC Cancer 8 (2008): 278.
  29. Omranipour R., et al. “Performance of the Gail Model for Breast Cancer Risk Assessment in Iranian Women”. Archives of Breast Cancer1 (2015): 27-31.
  30. Harirchi I., et al. “Breast cancer in Iran: a review of 903 case records”. Public Health2 (2000): 143-145.
×

Citation

Citation: Ziba Farajzadegan., et al. “Breast Cancer in Central Iran: Estimated Incidence and Trend in Isfahan Province During 30 Years”. Acta Scientific Gastrointestinal Disorders 4.2 (2021): 15-22.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor0.835

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US